KTTA

Pasithea Therapeutics Corp. (KTTA)

About Pasithea Therapeutics Corp. (KTTA)

Pasithea Therapeutics Corp. is a biotechnology company focused on the research and discovery of new and treatments for psychiatric and neurological disorders. The company was founded by Yassine Bendiabdallah and Lawrence J. Steinman on May 12, 2020 and is headquartered in Miami Beach, FL.

Details

Daily high

$0.96

Daily low

$0.90

Price at open

$0.91

52 Week High

$7.50

52 Week Low

$0.80

Market cap

5.8M

Dividend yield

0.00%

Volume

509,901

Avg. volume

13.1M

P/E ratio

-.09

Pasithea Therapeutics Corp. News